This panel featured Dr. Thomas Hutson, Dr. Saby George, Dr. Jeff Yorio, and Louise Gunter. Hutson: You all can jump in as you would like to. But the first question is, does immunotherapy affect other ...

Standardizing follow-up after kidney stone treatment may reduce ionizing radiation exposure, identify recurrences earlier, and avoid complications such as urosepsis and chronic kidney disease, ...

Chronic kidney disease affects more than 850 million people worldwide and continues to impose a heavy clinical and economic ...

Professor of Medicine at Harvard Medical School and Senior Investigator in the Section on Genetics and Epidemiology at Joslin Diabetes Center in Boston, MA. To facilitate translational research on ...

The US Food and Drug Administration's (FDA's) Circulatory System Devices Panel has deemed the ReCor Paradise Ultrasound Renal Denervation (uRDN) System safe and effective in lowering blood pressure ...

A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On Wednesday, the ...

Advisors on the US Food and Drug Administration’s Circulatory System Devices Panel voted today in support of the premarket approval (PMA) application for the Paradise Ultrasound Renal Denervation ...

Yale School of Medicine researchers have identified a biomarker panel that improves the assessment of chronic kidney disease (CKD) progression in children. Their findings are published in the Journal ...

An expert panel of US nephrologists and other health care providers unanimously agreed that secondary hyperparathyroidism treatment is often started too late in patients with chronic kidney disease. A ...